Selected article for: "accession ribose methyltransferase and antiviral drug"
Author: Bo Ram Beck; Bonggun Shin; Yoonjung Choi; Sungsoo Park; Keunsoo Kang
Title: Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model
  • Document date: 2020_2_2
    • ID: cszqykpu_15
    Snippet: In many cases, DTI prediction models serve as a tool to repurpose drugs to develop novel usages of existing drugs. However, the application of DTI prediction in the present study may be useful to control The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.01.31.929547 doi: bioRxiv preprint Table 1 . Drug-target interaction (DTI) prediction results of FDA approved antviral drugs available on m.....
    Document: In many cases, DTI prediction models serve as a tool to repurpose drugs to develop novel usages of existing drugs. However, the application of DTI prediction in the present study may be useful to control The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.01.31.929547 doi: bioRxiv preprint Table 1 . Drug-target interaction (DTI) prediction results of FDA approved antviral drugs available on markets against a novel coronavirus (2019-nCoV, NCBI reference sequence NC_045512.2) 3C-like proteinase (accession YP_009725301.1). Ritonavir is expressed in canonical and isomeric forms SMILES, and * indicates isomeric form SMILES of ritonavir. Table 3 . Drug-target interaction (DTI) prediction results of antiviral drugs available on markets against a novel coronavirus (2019-nCoV, NCBI reference sequence NC_045512.2) helicase (accession YP_009725308.1). Ritonavir is expressed in canonical and isomeric form SMILES, and * indicates isomeric form SMILES of ritonavir. The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org /10.1101 /10. /2020 The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.01.31.929547 doi: bioRxiv preprint Table 6 . Drug-target interaction (DTI) prediction results of anti-viral drugs available on markets against a novel coronavirus (2019-nCoV, NCBI reference sequence NC_045512.2) 2'-O-ribose methyltransferase (accession YP_009725311.1). The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org /10.1101 /10. /2020

    Search related documents:
    Co phrase search for related documents
    • anti viral drug and drug target: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • antiviral drug and drug repurpose: 1, 2
    • antiviral drug and drug target: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral drug and drug target interaction: 1, 2, 3, 4
    • antiviral drug and exist drug: 1
    • drug repurpose and DTI prediction: 1
    • drug repurpose and DTI prediction model: 1
    • drug target and DTI prediction: 1, 2, 3, 4, 5, 6
    • drug target and DTI prediction model: 1, 2, 3
    • drug target interaction and DTI prediction: 1, 2, 3
    • drug target interaction and DTI prediction model: 1, 2